English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Welcome to the start of yet another year with Seminars in Thrombosis & Hemostasis (STH). This is my 8th year as the Editor-in-Chief, andmy 11th year of editorial associationwith this journal, having originally served as a Regional Editor. First, I sincerely wish to thank all the contributors to STH over the past years, as well as the Guest Editors for these issues, and of course the current and past Senior and Associate Editors of the journal. There have been several changes to the editorial team. We have two new Senior Editors: Ton Lisman joins Marcel Levi as a second European Senior Editor, and Sam Schulman, a long-time Associate Editor of STH, joins Hau Kwaan as a second North American Senior Editor. We have also increased the ranks of Associate Editors, with the aim to have around 10 to 12 contributing issues from each of the “global regions” of America, Europe, and Asia-Pacific. I will also take this opportunity to thank the journal production team at Thieme Medical Publishers for their high production standards and for facilitating both the print and online issues of the journal. In particular, I would like to thank Subhankar De, the Production Editor for STH who now leads the production team. I also wish to thank Kelly Coffey, a Journals Coordinator for Thieme Medical Publishers, as well as other key people at Thieme, some of whom prefer to remain unnamed, for the additional support provided over recent years. This is also the time that we reflect on our journal’s impact factor, which for 2014 was 3.876, which represents a small rise from our 2013 impact factor of 3.693 (►Fig. 1). I am hopeful that this reflects a stabilization of the STH impact factor at around 4 over the coming years. In any case, the impact factor is not the only marker of journal “quality” that we should consider, given the existence of other biometric markers and the limitations of any individual marker (including the impact factor) as a “quality” indicator.1,2 As I also now do annually, the highest cited (2012/2013published) contributions3–43 from this journal are listed in ►Table 1 for the potential interest of the readership and contributing authors. These contributions identify those publications, most contributing to the 2014 impact factor, and each have now been cited 15 or more times in literature, with the top 11-listed articles having been cited 25 or more times. For those interested, the current listing can be compared with those of the most recently published top downloaded article listings from STH, the basis of the Eberhard F. Mammen “most popular” awards.44,45 Accordingly, I would like to thank all the contributors, guest editors, and the editorial team for bringing us the content that makes STH. Finally, a short note to confirm that, as always, we will continue to develop plans for the future content of this journal, andwe are confident that wewill be able to continue to bring its readers the high-quality journal that is expected from us. Currently confirmed topics for issues that we plan to publish over the next 12 or so months are listed in ►Table 2.

Welcome to Seminars in Thrombosis & Hemostasis 2016: New (2014) Impact Factor and Most Highly Cited Articles